Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Avalon GloboCare (ALBT) Divestments (2025 - 2026)

Avalon GloboCare filings provide 2 years of Divestments readings, the most recent being $280500.0 for Q1 2026.

On a quarterly basis, Divestments rose 195.26% to $280500.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $149635.0, a N/A change, with the full-year FY2025 number at -$35865.0, changed N/A from a year prior.
Divestments hit $280500.0 in Q1 2026 for Avalon GloboCare, up from -$824365.0 in the prior quarter.
In the past five years, Divestments ranged from a high of $693500.0 in Q3 2025 to a low of -$824365.0 in Q4 2025.